(2S)-p-SCN-Bn-NOTA - CAS 1206475-68-4

(2S)-p-SCN-Bn-NOTA - CAS 1206475-68-4 Catalog number: BADC-01429

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

(2S)-p-SCN-Bn-NOTA is an ADC linker used in the synthesis of antibody-drug conjugates (ADCs).

Category
ADCs Linker
Product Name
(2S)-p-SCN-Bn-NOTA
CAS
1206475-68-4
Catalog Number
BADC-01429
Molecular Formula
C20H26N4O6S
Molecular Weight
450.51
(2S)-p-SCN-Bn-NOTA

Ordering Information

Catalog Number Size Price Quantity
BADC-01429 -- $--
Inquiry
Description
(2S)-p-SCN-Bn-NOTA is an ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
Synonyms
1H-1,4,7-Triazonine-1,4,7-triacetic acid, hexahydro-2-[(4-isothiocyanatophenyl)methyl]-, (2S)-; (S)-2,2',2''-(2-(4-isothiocyanatobenzyl)-1,4,7-triazonane-1,4,7-triyl)triacetic acid; (2S)-Hexahydro-2-[(4-isothiocyanatophenyl)methyl]-1H-1,4,7-triazonine-1,4,7-triacetic acid; BNOTA; p-SCN-Bn-NOTA; S-2-(4-Isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid; (2S)-2-(4-Isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid; (S)-2-(4-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid
IUPAC Name
2-[(5S)-4,7-bis(carboxymethyl)-5-[(4-isothiocyanatophenyl)methyl]-1,4,7-triazonan-1-yl]acetic acid
Canonical SMILES
C1CN(CC(N(CCN1CC(=O)O)CC(=O)O)CC2=CC=C(C=C2)N=C=S)CC(=O)O
InChI
InChI=1S/C20H26N4O6S/c25-18(26)11-22-5-6-23(12-19(27)28)10-17(24(8-7-22)13-20(29)30)9-15-1-3-16(4-2-15)21-14-31/h1-4,17H,5-13H2,(H,25,26)(H,27,28)(H,29,30)/t17-/m0/s1
InChIKey
ABEIJMWLNYUWMD-KRWDZBQOSA-N
Density
1.37±0.1 g/cm3
Boiling Point
716.5±60.0°C at 760 mmHg

(2S)-p-SCN-Bn-NOTA, a versatile chelating agent, plays a pivotal role in radiolabeling biomolecules, particularly in the realm of medical imaging. Here are four key applications presented with a high degree of perplexity and burstiness:

Radiopharmaceutical Development: At the forefront of medical imaging, (2S)-p-SCN-Bn-NOTA is indispensable for synthesizing radiopharmaceuticals utilized in positron emission tomography (PET) and single-photon emission computed tomography (SPECT). By conjugating radioisotopes to biomolecules, it facilitates real-time visualization of specific biological processes within living organisms. This capability is paramount for early disease detection, monitoring treatment efficacy, and advancing biomedical research endeavors.

Cancer Imaging: In the field of oncology, (2S)-p-SCN-Bn-NOTA is harnessed to radiolabel antibodies or peptides that target tumor-specific antigens. This targeted imaging approach enables precise visualization of tumors and metastases, aiding in accurate cancer staging and assessment of disease progression. Oncologists can tailor individualized treatment strategies based on the unique characteristics of each patient's cancer, ultimately enhancing therapeutic outcomes.

Neurological Disorder Research: Exploring the intricacies of neurological disorders, such as Alzheimer's and Parkinson's diseases, (2S)-p-SCN-Bn-NOTA-labeled compounds offer valuable insights. By selectively binding to specific proteins or receptors in the brain, these compounds yield detailed images of pathological alterations, shedding light on disease mechanisms. This imaging modality empowers researchers to evaluate novel treatment approaches and deepen their understanding of complex neurological conditions.

Cardiac Imaging: In the realm of cardiovascular health, (2S)-p-SCN-Bn-NOTA is a critical component in the development of radiolabeled tracers for cardiac imaging applications. These tracers aid in assessing myocardial perfusion and detecting ischemic heart disease by precisely localizing radiotracers within the heart. This technology plays a crucial role in evaluating cardiac function, pinpointing areas of compromised blood flow, and informing accurate diagnoses and treatment strategies for various cardiac conditions.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Historical Records: (2S)-p-SCN-Bn-NOTA
Why Choose BOC Sciences?

Customer Support

Providing excellent 24/7 customer service and support

Project Management

Offering 100% high-quality services at all stages

Quality Assurance

Ensuring the quality and reliability of products or services

Global Delivery

Ensuring timely delivery of products worldwide

Questions & Comments
Verification code
Send Inquiry
Verification code
Inquiry Basket